Literature DB >> 10524285

Serum amyloid A1 alleles and plasma concentrations of serum amyloid A.

T Yamada1, A Wada, Y Itoh, K Itoh.   

Abstract

Serum amyloid A1 (SAA1), the predominant isotype of acute phase SAA in plasma and the predominant precursor of fibrillar deposits in reactive amyloidosis, is encoded by a gene, for which six allelic variants have been described. Recent studies proposed that the allele SAA1.3 was positively correlated with the development of reactive amyloidosis in Japanese. This study examined whether the plasma concentration of total SAA is influenced by specific SAA1 alleles. Two hundred and eighty healthy Japanese subjects were examined to determine the allelic distribution of SAA1 and SAA2 genes by the PCR-RFLP method, and to measure the total plasma SAA concentrations. SAA concentrations were significantly higher (p < 0.001) in subjects with the allele SAA1.5 than those without it, suggesting that SAA1.5 may have a distinctive feature in the process of synthesis or catabolism. Subjects with the allele SAA1.3 had lower SAA concentrations, though not statistically significant, than those with SAA1.1. There was not significant correlation of SAA2 alleles with SAA concentrations. These results are discussed in terms of amyloidogenicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524285     DOI: 10.3109/13506129909007327

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  16 in total

1.  Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Zhe Dong; Tingting Wu; Weidong Qin; Chuankai An; Zhihao Wang; Mingxiang Zhang; Yun Zhang; Cheng Zhang; Fengshuang An
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

2.  Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis.

Authors:  T Yamada; Y Okuda; K Takasugi; K Itoh; J Igari
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes.

Authors:  Kayleigh Griffiths; Alexander P Maxwell; Rachel V McCarter; Patrick Nicol; Ruth E Hogg; Mark Harbinson; Gareth J McKay
Journal:  Ir J Med Sci       Date:  2019-03-09       Impact factor: 1.568

4.  Development of quantitative mass spectrometric immunoassay for serum amyloid A.

Authors:  Olgica Trenchevska; Hussein N Yassine; Chad R Borges; Randall W Nelson; Dobrin Nedelkov
Journal:  Biomarkers       Date:  2016-07-22       Impact factor: 2.658

5.  The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.

Authors:  F Yalçinkaya; N Cakar; B Acar; E Tutar; H Güriz; A H Elhan; S Oztürk; A Kansu; E Ince; S Atalay; N Girgin; U Doğru; D Aysev; M Ekim
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

6.  Effect of serum amyloid A1 treatment on global gene expression in THP-1-derived macrophages.

Authors:  Koon-Yeow Leow; Wilson Wen Bin Goh; Chew-Kiat Heng
Journal:  Inflamm Res       Date:  2012-01-08       Impact factor: 4.575

7.  Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever.

Authors:  C Cazeneuve; H Ajrapetyan; S Papin; F Roudot-Thoraval; D Geneviève; E Mndjoyan; M Papazian; A Sarkisian; A Babloyan; B Boissier; P Duquesnoy; J C Kouyoumdjian; E Girodon-Boulandet; G Grateau; T Sarkisian; S Amselem
Journal:  Am J Hum Genet       Date:  2000-10-03       Impact factor: 11.025

8.  Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey.

Authors:  Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Zhen-Yan Fu; Xiao-Mei Li; Ding Huang; Xiang Ma; Bang-Dang Chen; Fen Liu
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

9.  Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A.

Authors:  Carola Marzi; Eva Albrecht; Pirro G Hysi; Vasiliki Lagou; Melanie Waldenberger; Anke Tönjes; Inga Prokopenko; Katharina Heim; Hannah Blackburn; Janina S Ried; Marcus E Kleber; Massimo Mangino; Barbara Thorand; Annette Peters; Christopher J Hammond; Harald Grallert; Bernhard O Boehm; Peter Kovacs; Ludwig Geistlinger; Holger Prokisch; Bernhard R Winkelmann; Tim D Spector; H-Erich Wichmann; Michael Stumvoll; Nicole Soranzo; Winfried März; Wolfgang Koenig; Thomas Illig; Christian Gieger
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

Review 10.  New advances in renal amyloidosis.

Authors:  Shinichi Nishi; Bassam Alchi; Nofumi Imai; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.